John McCoy
Presidente en CARDIOVASCULAR SYSTEMS, INC. .
Fortuna: 2 M $ al 31/05/2024
Cargos activos de John McCoy
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CARDIOVASCULAR SYSTEMS, INC. | Presidente | - | - |
| Treasurer | - | - | |
| ABBOTT LABORATORIES | Comptroller/Controller/Auditor | 01/09/2023 | - |
| Corporate Officer/Principal | 01/01/2018 | 01/01/2021 | |
| Treasurer | 01/01/2021 | 01/09/2023 |
Historial de carrera de John McCoy
Antiguos cargos conocidos de John McCoy.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| BAXALTA INC | Comptroller/Controller/Auditor | 01/06/2015 | 01/01/2016 |
Estadísticas
Internacional
| Estados Unidos | 4 |
Operativa
| Comptroller/Controller/Auditor | 2 |
| Treasurer | 2 |
| President | 1 |
Sectorial
| Health Technology | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| Empresas privadas | 2 |
|---|---|
Baxalta, Inc.
 Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
Cardiovascular Systems, Inc.
 Cardiovascular Systems, Inc. Medical SpecialtiesHealth Technology Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The company was founded in 1989 and is headquartered in St. Paul, MN. | Health Technology |
- Bolsa de valores
- Insiders
- John McCoy
- Experiencia
